CSL Behring GmbH, a leading global biotechnology company, is headquartered in Austria (AT) and operates extensively across Europe, North America, and Asia. Founded in 1904, CSL Behring has established itself as a pioneer in the development of innovative therapies for rare and serious medical conditions, particularly in the fields of immunology, haematology, and respiratory health. The company is renowned for its high-quality plasma-derived therapies, including immunoglobulins and clotting factor concentrates, which are essential for patients with immune deficiencies and bleeding disorders. CSL Behring's commitment to research and development has positioned it as a market leader, with notable achievements in advancing treatment options and improving patient outcomes. With a strong focus on patient care and scientific excellence, CSL Behring continues to make significant contributions to the biopharmaceutical industry.
How does CSL Behring GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
CSL Behring GmbH's score of 30 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CSL Behring GmbH, headquartered in Austria (AT), currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. In the absence of detailed emissions data, it is important to note that CSL Behring is committed to addressing climate change through various initiatives. However, no specific reduction targets or climate pledges have been disclosed. The company operates within an industry that is increasingly focused on sustainability and reducing carbon footprints, indicating a potential alignment with broader environmental goals. As the landscape of corporate climate commitments evolves, CSL Behring's future actions and disclosures will be crucial in understanding their impact on carbon emissions and climate change mitigation.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CSL Behring GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.